Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis

American Journal of Obstetrics and Gynecology - Tập 145 - Trang 422-426 - 1983
Anthony A. Luciano1,2,3, Katherine S. Hauser1,2,3, Frederick K. Chapler1,2,3, William A. Davis1,2,3, Robert B. Wallace1,2,3
1Department of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa, USA
2Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA
3the Clinical Research Center, University of Iowa Iowa City, Iowa USA

Tài liệu tham khảo

Greenblatt, 1971, Clinical studies with an antigonadotropin—danazol, Fertil. Steril, 22, 102, 10.1016/S0015-0282(16)38045-1 Dmowski, 1979, Endocrine properties and clinical application of danazol, Fertil. Steril, 31, 237, 10.1016/S0015-0282(16)43869-0 Alfin-Slater, 1972, Lipids and the pill, Lipids, 6, 693, 10.1007/BF02531293 Beck, 1973, Contraceptive steroids: Modifications of carbohydrate and lipid metabolism, Metabolism, 22, 841, 10.1016/0026-0495(73)90056-5 Mann, 1975, Myocardial infarction in young women with special reference to oral contraceptive practice, Br. Med. J, 2, 241, 10.1136/bmj.2.5965.241 Blackard, 1970, Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate, Cancer, 26, 249, 10.1002/1097-0142(197008)26:2<249::AID-CNCR2820260202>3.0.CO;2-7 Phillips, 1976, Evidence for hyperoestrogenemia as a risk factor for myocardial infarction in men, Lancet, 2, 14, 10.1016/S0140-6736(76)92968-8 Ross, 1981, Menopausal oestrogen therapy and protection from death from ischemic heart disease, Lancet, 1, 858, 10.1016/S0140-6736(81)92138-3 Fraser, 1979, Danazol and cholesterol metabolism, Lancet, 1, 931, 10.1016/S0140-6736(79)91416-8 Wynn, 1977, Metabolic effects of danazol, J. Int. Med. Res, 2, 25 Malkonen, 1980, Effects of danazol and lynestrenol on serum lipoproteins in endometriosis, Clin. Pharmacol. Ther, 28, 602, 10.1038/clpt.1980.209 Allen, 1981, Cholesterol, high density lipoprotein, and danazol, J. Clin. Endocrinol. Metab, 53, 149, 10.1210/jcem-53-1-149 Luciano, 1982, Effects of Danazol on plasma lipid and lipoprotein levels in normal women, Atherosclerosis, 43, 133, 10.1016/0021-9150(82)90105-8 Gordon, 1977, High-density lipoprotein as a protective factor against coronary heart disease: The Framingham Study, Am. J. Med, 62, 707, 10.1016/0002-9343(77)90874-9 Miller, 1981, Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins, Br. Med. J, 282, 1741, 10.1136/bmj.282.6278.1741 Miller, 1974, Manual of Laboratory Operations, Lipid Research Clinics Program, Vol. 1, 628 Witztum, 1979, High density lipoproteins, Diabetes, 28, 326, 10.2337/diab.28.4.326 Oster, 1982, Effects of estrogens and progestrogens on lipid metabolism, Am. J. Obstet. Gynecol, 142, 773, 10.1016/S0002-9378(16)32487-5 Luciano, 1981, Danazol: Endocrine consequences in healthy women, Am. J. Obstet. Gynecol, 141, 5, 10.1016/S0002-9378(15)33318-4 Glueck, 1971, Norethindrone acetate, postheparin lipolypic activity, and plasma triglycerides in familial types I, II, IV, and V hyperlipoproteinemia, Ann. Intern. Med, 75, 345, 10.7326/0003-4819-75-3-345